SymBio Pharmaceuticals Limited Logo

SymBio Pharmaceuticals Limited

Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.

4582 | T

Overview

Corporate Details

ISIN(s):
JP3383050006
LEI:
Country:
Japan
Address:
港区虎ノ門四丁目1番28号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SymBio Pharmaceuticals Limited is a specialty pharmaceutical company dedicated to addressing unmet medical needs. Its core business model involves acquiring the rights to develop and commercialize promising new drug candidates from global bio-ventures and pharmaceutical firms. The company focuses on therapeutic areas including oncology, hematology, autoimmune diseases, and infectious diseases. SymBio aims to deliver innovative treatments to patients, particularly for conditions underserved by the broader industry, with a primary market focus on Japan and the Asia-Pacific region.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-05 02:11
Registration Form
確認書
Japanese 9.0 KB
2025-08-04 09:05
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 281.2 KB
2025-08-04 09:04
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 356.9 KB
2025-07-31 08:37
Registration Form
訂正有価証券届出書(参照方式)
Japanese 276.5 KB
2025-07-22 09:24
Registration Form
有価証券届出書(参照方式)
Japanese 524.8 KB
2025-04-21 03:23
Share Issue/Capital Change
訂正臨時報告書
Japanese 36.1 KB
2025-04-18 09:38
Share Issue/Capital Change
訂正臨時報告書
Japanese 40.4 KB
2025-03-26 05:29
Registration Form
訂正有価証券届出書(参照方式)
Japanese 207.2 KB
2025-03-26 05:04
Post-Annual General Meeting Information
臨時報告書
Japanese 26.2 KB
2025-03-25 07:35
Share Issue/Capital Change
臨時報告書
Japanese 44.1 KB
2025-03-25 07:34
Registration Form
訂正有価証券届出書(参照方式)
Japanese 312.0 KB
2025-03-25 07:32
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-25 07:31
Registration Form
確認書
Japanese 9.0 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.9 MB
2025-02-20 08:20
Registration Form
訂正有価証券届出書(参照方式)
Japanese 241.9 KB

Automate Your Workflow. Get a real-time feed of all SymBio Pharmaceuticals Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SymBio Pharmaceuticals Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SymBio Pharmaceuticals Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America
ADVM
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France
ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden
AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan
2927
AGENUS INC Logo
Develops antibodies, cell therapies & adjuvants to harness the immune system against cancer.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
United States of America
AGIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.